{"disease":{"id":"ibi363-chemotherapy","name":"ibi363 chemotherapy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07325630","title":"Perioprative Study of IBI363 in Patients With MHC-II-Negative Locally Advanced Gastric Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Zhejiang Cancer Hospital","has_results":false},{"nct_id":"NCT06610799","title":"Study of IBI363 in Patients with Advanced First-line Gastric Cancer","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Xiangdong Cheng","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}